Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketogenic Intervention in Depression
NCT06080932Completed
- Sponsor
- The Ohio State University
- Start
- Feb 2023
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in major depressive disorder (MDD), sponsored by The Ohio State University. Primary endpoints: World Health Organization-Five Well-Being Index at 12 weeks, Hamilton Depression Scale at 12 weeks and 2 more. Started Feb 2023; status: completed.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06080932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06080932.